Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation

Slides:

Advertisements

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Challenging homografts as the holy grail for aortic valve endocarditis

Surgery for congenital diseases of the aorta

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Pulmonary hypertension in valve disease: A beast of the past?

Intrinsic cardiac stem cells are essential for regeneration

Are preoperative B-type natriuretic peptide levels associated with outcome after pulmonary artery banding and the double switch operation in patients.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

William M. DeCampli, MD, PhD

Application of a neuroscience research model to study neuroprotection in children with congenital heart disease Nobuyuki Ishibashi, MD, Richard A. Jonas,

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

The lord of the rings Antonio Miceli, MD, PhD

Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment Herko Grubitzsch, MD, PhD, Andreas Schaefer, Christoph.

The variability of the mitral valve anatomy and terminology

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Michele Gallo, MD, Gino Gerosa, MD

A first start for lung transplantation?

Effective transcatheter valve implantation after pulmonary homograft failure: A new perspective on the Ross operation Johannes Nordmeyer, MD, Philipp.

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Taking UP the chronic pulmonary obstructive disease gauntlet

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Biomaterials for heart valve replacement: Conjectures and refutations

Who is your plastic surgeon

Atypical malignant late infective endocarditis of Melody valve

James I. Fann, MD, John E. Connolly, MD

Innovation in cardiothoracic surgical training

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Hope should not spring eternal

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

The continuing challenge of congenital heart disease in China

Commentary: When a choice is not an echo

Andrew Bridgeman, MBChB, BSc, Umberto Benedetto, MD, PhD

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Commentary: All aboard the transcatheter express—Road map for surgeons to develop expertise in catheter-based treatment of structural heart disease Grayson.

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Preoperative PFTs: The answer is blowing in the wind

Did you like Terminator 3 better than Terminator 2

How do we follow up our patients

Lessons learned from Melody valve retrieved at transplantation

Deciding how much to pay for effective care

Presentation transcript:

Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation Sophie Malekzadeh-Milani, MD, Magalie Ladouceur, MD, Laurence Iserin, MD, Damien Bonnet, MD, PhD, Younes Boudjemline, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 5, Pages 2253-2259 (November 2014) DOI: 10.1016/j.jtcvs.2014.07.097 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Freedom from infective endocarditis in the surgical group and the percutaneous pulmonary valve implantation (Melody valve) group. IE, Infective endocarditis; PPVI, percutaneous pulmonary valve implantation. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2253-2259DOI: (10.1016/j.jtcvs.2014.07.097) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Survival curve in the surgical group and the percutaneous pulmonary valve implantation (Melody valve) group. PPVI, Percutaneous pulmonary valve implantation. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2253-2259DOI: (10.1016/j.jtcvs.2014.07.097) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Freedom from cardiovascular events in the surgical group and the percutaneous pulmonary valve implantation (Melody valve) group. PPVI, Percutaneous pulmonary valve implantation. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2253-2259DOI: (10.1016/j.jtcvs.2014.07.097) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions